MORGAN STANLEY - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$76,637,673
+21.6%
4,829,091
+44.6%
0.01%
+33.3%
Q2 2023$62,999,477
+124.1%
3,338,605
-54.4%
0.01%
+100.0%
Q1 2023$28,107,642
+33.2%
7,319,698
+72.0%
0.00%
+50.0%
Q4 2022$21,105,891
-6.9%
4,255,220
-10.3%
0.00%
-33.3%
Q3 2022$22,673,000
-8.2%
4,743,474
-13.5%
0.00%0.0%
Q2 2022$24,686,000
-1.1%
5,485,767
+4.6%
0.00%0.0%
Q1 2022$24,962,000
-20.0%
5,244,620
+24.7%
0.00%
-25.0%
Q4 2021$31,219,000
+46.3%
4,207,355
+11.8%
0.00%
+33.3%
Q3 2021$21,343,000
-24.4%
3,764,338
-12.2%
0.00%
-25.0%
Q2 2021$28,248,000
-17.0%
4,286,501
+2.0%
0.00%
-20.0%
Q1 2021$34,053,000
+13.6%
4,203,979
-9.5%
0.01%0.0%
Q4 2020$29,968,000
+363.6%
4,646,239
+158.7%
0.01%
+400.0%
Q3 2020$6,464,000
+114.0%
1,795,649
+173.4%
0.00%0.0%
Q2 2020$3,021,000
+21.3%
656,716
-10.1%
0.00%0.0%
Q1 2020$2,491,000
-89.0%
730,660
-83.5%
0.00%
-80.0%
Q4 2019$22,629,000
+240.5%
4,432,696
+61.4%
0.01%
+150.0%
Q3 2019$6,646,000
-47.5%
2,745,852
-52.9%
0.00%
-33.3%
Q2 2019$12,659,000
+39.8%
5,833,867
+74.6%
0.00%0.0%
Q1 2019$9,053,000
-64.8%
3,340,830
-37.7%
0.00%
-62.5%
Q4 2018$25,728,000
-3.2%
5,360,198
+91.0%
0.01%
+14.3%
Q3 2018$26,578,000
-22.5%
2,806,478
-20.4%
0.01%
-22.2%
Q2 2018$34,306,000
-10.8%
3,525,775
-3.5%
0.01%
-18.2%
Q1 2018$38,449,000
+53.9%
3,654,810
-6.2%
0.01%
+57.1%
Q4 2017$24,979,000
+230.3%
3,896,710
+294.2%
0.01%
+250.0%
Q3 2017$7,563,000
+3.8%
988,509
-3.5%
0.00%0.0%
Q2 2017$7,283,000
-21.5%
1,024,470
-57.3%
0.00%
+100.0%
Q1 2017$9,280,000
+79.6%
2,397,186
-5.4%
0.00%0.0%
Q4 2016$5,168,000
+70.5%
2,533,934
+124.0%
0.00%0.0%
Q3 2016$3,031,000
-60.4%
1,131,061
-54.5%
0.00%
-66.7%
Q2 2016$7,659,000
+1.1%
2,486,662
+179.6%
0.00%0.0%
Q1 2016$7,577,000
-37.2%
889,268
+0.0%
0.00%
-25.0%
Q4 2015$12,066,000
+34.8%
889,205
-4.7%
0.00%
+33.3%
Q3 2015$8,954,000
-43.2%
932,683
-15.0%
0.00%
-40.0%
Q2 2015$15,773,000
+87.6%
1,096,827
+16.8%
0.01%
+66.7%
Q1 2015$8,406,000
+38.0%
939,263
-5.9%
0.00%
+50.0%
Q4 2014$6,091,000
-42.2%
998,544
+0.3%
0.00%
-50.0%
Q3 2014$10,547,000
+7.6%
995,994
+20.4%
0.00%0.0%
Q2 2014$9,800,000
+107.0%
826,965
+160.8%
0.00%
+100.0%
Q1 2014$4,735,000
-18.0%
317,128
-19.4%
0.00%0.0%
Q4 2013$5,774,000
-26.8%
393,625
-15.0%
0.00%
-50.0%
Q3 2013$7,883,000
+5.9%
463,112
+3.2%
0.00%0.0%
Q2 2013$7,444,000448,7410.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders